Evaluation of the Safety and Efficacy of Teneligliptin at a Higher Dose in Indian Type 2 Diabetes Patients: A Retrospective Analysis

Background and aim While diabetes mellitus (DM) is occupying the topmost global epidemic position, India is harboring a challenging number of type 2 DM patients in the world. This devastating picture of the health sector in India requires the availability of more cost-effective, context-specific, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitra, Asis, Ray, Saswati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047936/
https://www.ncbi.nlm.nih.gov/pubmed/32140368
http://dx.doi.org/10.7759/cureus.6812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047936/
https://www.ncbi.nlm.nih.gov/pubmed/32140368
http://dx.doi.org/10.7759/cureus.6812

Ejemplares similares